Last updated 15 days ago
DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)
500 patients around the world
Available in Puerto Rico, United States, Chile
Merck Sharp & Dohme LLC
7Research sites
500Patients around the world
This study is for people with
Hiv
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Clínico de la Universidad de Chile - Santiago
Recruiting
Biomedica Research Group
Recruiting
Hospital Dr. Hernán Henríquez Aravena
Recruiting
Espacio EME
Recruiting
Clínica Universidad Católica del Maule
Recruiting
Clinical Research Puerto Rico
Recruiting
Ponce Medical School Foundation Inc
Recruiting
SponsorMerck Sharp & Dohme LLC
Conditions
Hiv
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05705349
